Stocks and Investing
Stocks and Investing
Fri, January 27, 2023
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
Matt Miksic Maintained (ABT) at Buy with Increased Target to $125 on, Jan 27th, 2023
Matt Miksic of Barclays, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $122 to $125 on, Jan 27th, 2023.
Matt has made no other calls on ABT in the last 4 months.
There are 16 other peers that have a rating on ABT. Out of the 16 peers that are also analyzing ABT, 2 agree with Matt's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Anthony Petrone of "Mizuho" Maintained at Hold with Increased Target to $110 on, Tuesday, January 24th, 2023
- Matthew Taylor of "Jefferies" Initiated at Hold and Held Target at $110 on, Wednesday, October 12th, 2022
These are the ratings of the 14 analyists that currently disagree with Matt
- Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $123 on, Thursday, January 26th, 2023
- Lee Hambright of "Bernstein" Maintained at Buy with Increased Target to $132 on, Thursday, January 26th, 2023
- Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $125 on, Thursday, January 26th, 2023
- Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $125 on, Thursday, January 26th, 2023
- Mike Polark of "Wolfe Research" Maintained at Sell with Increased Target to $107 on, Wednesday, January 25th, 2023
- Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Increased Target to $133 on, Friday, January 6th, 2023
- Joshua Jennings of "TD Cowen" Maintained at Buy and Held Target at $130 on, Tuesday, December 13th, 2022
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $125 on, Monday, December 12th, 2022
- Robbie Marcus of "JP Morgan" Maintained at Buy with Decreased Target to $118 on, Thursday, October 20th, 2022
- Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $126 on, Thursday, October 20th, 2022
- Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $114 on, Thursday, October 20th, 2022
- Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Decreased Target to $110 on, Wednesday, October 19th, 2022
- Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Decreased Target to $123 on, Monday, October 17th, 2022
- Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $140 on, Monday, October 10th, 2022
Contributing Sources